Vidyalakshmi Chandramohan
Associate Professor in NeurosurgeryOverview
The research work in my laboratory focuses on identifying novel immunotherapeutic targets for the treatment of brain tumors, specifically glioblastoma (GBM). My previous work includes the development of the dual-specific immunotoxin (IT) D2C7-IT, which is currently in Phase I clinical trials in recurrent GBM (rGBM) patients. My current research seeks to identify novel strategies to enhance the efficacy of D2C7-IT and other GBM-targeted cytotoxic therapies. In conjunction with this, my research includes the investigation of immune-related biomarkers to predict the clinical outcome of D2C7-IT therapy in patients with GBM.
Positions
Associate Professor in Neurosurgery in the School of Medicine
2021 School of Medicine
Associate Professor in Pathology in the School of Medicine
2020 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2015 School of Medicine
Education
Ph.D., Boston University 2006
2006 Boston University
M.B.A., North Carolina State University 2020
2020 North Carolina State University
Postdoctoral Associate, Duke University, School of Medicine, SURGERY 2005 - 2007
2007 Duke University, School of Medicine
Research Associate, Duke University, School of Medicine, PATHOLOGY 2007 - 2010
2010 Duke University, School of Medicine
Research Associate, Sr, Duke University, School of Medicine, PATHOLOGY 2010 - 2012
2012 Duke University, School of Medicine
Publications, Grants & Awards
Offices & Contact
185 MSRB
Durham, NC
27710
Box 3156 Med Ctr
Durham, NC
27710